The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict ICU Medical's revenues will increase 8.2% and EPS will contract -37.3%.
The average estimate for revenue is $82.7 million. On the bottom line, the average EPS estimate is $0.79.
Last quarter, ICU Medical logged revenue of $81.4 million. GAAP reported sales were 6.5% higher than the prior-year quarter's $76.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.82. GAAP EPS of $0.82 for Q3 were 26% higher than the prior-year quarter's $0.65 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 50.0%, 350 basis points better than the prior-year quarter. Operating margin was 21.5%, 410 basis points better than the prior-year quarter. Net margin was 15.0%, 290 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $316.9 million. The average EPS estimate is $2.77.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 85 members out of 98 rating the stock outperform, and 13 members rating it underperform. Among 29 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 27 give ICU Medical a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on ICU Medical is outperform, with an average price target of $62.50.
Is ICU Medical the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add ICU Medical to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. TMFDisclosureHere